share_log

辰欣药业(603367.SH)发布2023年度业绩，净利润5.21亿元，同比增长48.97%

Chenxin Pharmaceutical (603367.SH) announced its 2023 annual results, with net profit of 521 million yuan, an increase of 48.97% over the previous year

Zhitong Finance ·  Apr 22 19:30

Chenxin Pharmaceutical (603367.SH) disclosed its 2023 annual report, and the company achieved 44 revenue in 2023...

According to the Zhitong Finance App, Chen Xin Pharmaceutical (603367.SH) disclosed its 2023 annual report. The company achieved revenue of 4.462 billion yuan in 2023, up 9.75% year on year; net profit to mother of 521 million yuan, up 48.97% year on year; after deducting non-net profit of 451 million yuan, up 36.21% year on year; basic income per share was 1.15 yuan. The company plans to pay a cash dividend of 4.36 yuan (tax included) for every 10 shares.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment